Mutant PIK3CA Controls DUSP1-dependent ERK 1/2 Activity to Confer Response to AKT Target Therapy
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2014.534
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Springer Science and Business Media LLC